Beyond Biotech, 5 ETFs Up At Least 10% In Q4

 | Dec 11, 2019 08:00PM ET

Biotech stocks and ETFs have been going through the roof in the fourth quarter. Mergers and acquisitions, especially in the hot cancer treatment space, positive drug data, FDA approvals, upbeat financials and decent valuations are making the space a clear winner. As a result, Virtus LifeSci Biotech Clinical Trials ETF (ASX:BBC) is up as much as 51% this quarter, thus being the the best ETF of the quarter so far (read: GNOM gaining 28.7% and so on. But the ongoing quarter is not just about biotech. There are other ETFs that are seeing solid momentum. Below we highlight a few:

iPath Series B Bloomberg Coffee Subindex Total Return ETN JO – Up 29.3%

Coffee futures in the March contract is hovering around a two-year high thanks to Top & Flop ETFs of November) .

Global X MSCI Pakistan ETF (ASX:PAK) – Up 26.9%

The Pakistan Stock Exchange has been riding high of late. “Extended Fund Facility worth $6 billion .

Global X MSCI China Real Estate ETF (SI:CHIR) – Up 16.7%

China has been witnessing a red hot real-estate market with property prices surging in big cities. In any case, Chinese shares have been benefiting in recent trading on trade deal hopes by mid-December. Affordable home loans are another positive.

ETFMG Prime Junior Silver ETF SILJ – Up 15.3%

With the Fed remaining dovish, the U.S. dollar remained subdued. Invesco DB US Dollar Index Bullish Fund UUP has lost 0.5% in the past three months (as of Dec 11, 2019). This boosted metal prices as these are mostly priced in the greenback. Also, silver acts as a safe-haven asset and gets a boost from geopolitical tensions. SILJ provides direct global exposure to small-cap securities in the silver mining exploration and production industry by tracking the Prime Junior Silver Miners & Explorers Index.

Claymore/Delta Global Shipping (TSX:SEA) – Up 14.3%

Very large crude carriers’ (VLCC) rates spiked to all-time highs in October. The reasons were the Trump administration’s imposition of sanctions were levied for carrying crude to China from Iran.

Plus, Platts Analytics expects about 60 VLCCs to move to dry docks in the fourth quarter ahead of the implementation of IMO 2020 regulations. Each scrubber installation requires around Top and Flop ETFs of October ).

Want key ETF info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Zacks Investment Research

Get The News You Want
Read market moving news with a personalized feed of stocks you care about.
Get The App

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Sign out
Are you sure you want to sign out?
NoYes
CancelYes
Saving Changes